MA28544B1 - Facteur de permissivité cellulaire pour virus, et leurs utilisations - Google Patents

Facteur de permissivité cellulaire pour virus, et leurs utilisations

Info

Publication number
MA28544B1
MA28544B1 MA29400A MA29400A MA28544B1 MA 28544 B1 MA28544 B1 MA 28544B1 MA 29400 A MA29400 A MA 29400A MA 29400 A MA29400 A MA 29400A MA 28544 B1 MA28544 B1 MA 28544B1
Authority
MA
Morocco
Prior art keywords
viruses
cell
factor
permissivity factor
cell permissivity
Prior art date
Application number
MA29400A
Other languages
English (en)
Inventor
Jay Gregory Calvert
Shelly Lynn Shields
David Ewell Slade
Siao-Kun Wan Welch
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of MA28544B1 publication Critical patent/MA28544B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
MA29400A 2004-04-23 2006-10-20 Facteur de permissivité cellulaire pour virus, et leurs utilisations MA28544B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09

Publications (1)

Publication Number Publication Date
MA28544B1 true MA28544B1 (fr) 2007-04-03

Family

ID=35320736

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29400A MA28544B1 (fr) 2004-04-23 2006-10-20 Facteur de permissivité cellulaire pour virus, et leurs utilisations

Country Status (22)

Country Link
US (4) US7754464B2 (fr)
EP (2) EP2520310B1 (fr)
JP (2) JP5273642B2 (fr)
CN (1) CN102220289B (fr)
AR (3) AR049033A1 (fr)
AU (2) AU2005240002B2 (fr)
BR (1) BRPI0508928B1 (fr)
CA (1) CA2564769C (fr)
CL (1) CL2008002323A1 (fr)
DK (1) DK1742658T3 (fr)
EA (1) EA013071B1 (fr)
ES (2) ES2570665T3 (fr)
HK (1) HK1109065A1 (fr)
IL (1) IL178160A0 (fr)
MA (1) MA28544B1 (fr)
MX (1) MXPA06012216A (fr)
NO (1) NO341211B1 (fr)
NZ (1) NZ550145A (fr)
PL (1) PL1742658T3 (fr)
TW (2) TWI438278B (fr)
UY (1) UY28867A1 (fr)
WO (1) WO2005107796A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2570665T3 (es) * 2004-04-23 2016-05-19 Zoetis Services Llc Factor de permisividad celular para virus, y usos del mismo
ES2560432T3 (es) 2007-01-12 2016-02-19 The Board Of Trustees Of The University Of Illinois Células no símicas para el desarrollo del virus del síndrome reproductivo y respiratorio porcino (PRRS)
US8420373B2 (en) * 2007-07-27 2013-04-16 Universiteit Gent Permissive cells and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
JP6386999B2 (ja) * 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群（ｐｒｒｓ）ウイルスに対する離乳前の効果的なワクチン接種
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
WO2018112169A2 (fr) 2016-12-14 2018-06-21 Zoetis Services Llc Vaccination efficace contre les souches européennes du virus du syndrome reproducteur et respiratoire porcin (srrp) avant le sevrage
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫***重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (fr) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Methode pour la detection de liants specifiques et des substances liables par ceux-ci
CA1303983C (fr) 1987-03-27 1992-06-23 Robert W. Rosenstein Essai en phase solide
WO1990005183A1 (fr) 1988-10-31 1990-05-17 Immunex Corporation Recepteurs d'interleukine-4
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
JP3501286B2 (ja) 1989-12-22 2004-03-02 アプライド リサーチ システムズ，エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
WO1991018982A1 (fr) 1990-06-05 1991-12-12 Immunex Corporation Recepteurs de l'interleukine-1 de type ii
EP0539573A4 (en) 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
DE69432791T2 (de) 1993-05-28 2004-06-03 Baylor College Of Medicine, Houston Verfahren und massenspektrometer zur desorption und ionisierung von analyten
ATE206455T1 (de) * 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (fr) * 1997-02-07 1998-08-13 Origen, Inc. Procede servant a cultiver le virus du syndrome respiratoire et reproductif porcin afin de l'utiliser en tant que vaccin et dans des essais diagnostiques
US6740490B2 (en) 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
US7563881B2 (en) 2001-07-24 2009-07-21 Intervet International B.V. Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus
AU2003243058A1 (en) * 2002-05-27 2003-12-12 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
ES2570665T3 (es) * 2004-04-23 2016-05-19 Zoetis Services Llc Factor de permisividad celular para virus, y usos del mismo

Also Published As

Publication number Publication date
JP5273642B2 (ja) 2013-08-28
EP2520310A1 (fr) 2012-11-07
ES2530694T3 (es) 2015-03-04
HK1109065A1 (en) 2008-05-30
US8486685B2 (en) 2013-07-16
AU2005240002B2 (en) 2009-06-18
TWI438278B (zh) 2014-05-21
US8058050B2 (en) 2011-11-15
EA200601677A1 (ru) 2007-10-26
US9102912B2 (en) 2015-08-11
CN102220289B (zh) 2014-05-21
IL178160A0 (en) 2006-12-31
AR084530A2 (es) 2013-05-22
EP1742658B1 (fr) 2014-12-24
NO341211B1 (no) 2017-09-11
DK1742658T3 (en) 2015-01-19
CN102220289A (zh) 2011-10-19
TWI354025B (en) 2011-12-11
TW201134944A (en) 2011-10-16
EP2520310B1 (fr) 2016-03-30
NO20065115L (no) 2006-11-06
US20120015425A1 (en) 2012-01-19
AR084529A2 (es) 2013-05-22
CA2564769C (fr) 2013-12-17
NZ550145A (en) 2009-07-31
WO2005107796A2 (fr) 2005-11-17
US20140141492A1 (en) 2014-05-22
US7754464B2 (en) 2010-07-13
JP2007533321A (ja) 2007-11-22
UY28867A1 (es) 2005-11-30
AU2009202410A1 (en) 2009-07-09
EA013071B1 (ru) 2010-02-26
US20050271685A1 (en) 2005-12-08
JP2013078324A (ja) 2013-05-02
MXPA06012216A (es) 2007-01-17
ES2570665T3 (es) 2016-05-19
TW200604343A (en) 2006-02-01
BRPI0508928B1 (pt) 2015-10-06
JP5600340B2 (ja) 2014-10-01
EP1742658A4 (fr) 2007-11-28
CA2564769A1 (fr) 2005-11-17
CL2008002323A1 (es) 2008-12-19
US20100273238A1 (en) 2010-10-28
AU2005240002A1 (en) 2005-11-17
BRPI0508928A (pt) 2007-08-14
EP1742658A2 (fr) 2007-01-17
PL1742658T3 (pl) 2015-05-29
AR049033A1 (es) 2006-06-21
WO2005107796A3 (fr) 2007-04-12

Similar Documents

Publication Publication Date Title
MA28544B1 (fr) Facteur de permissivité cellulaire pour virus, et leurs utilisations
DE602006012336D1 (de) Radikalische atomtransfer-polymerisation in mikroemulsion und echte emulsionspolymerisation
MA27035A1 (fr) Ligands de recepteurs de 5-ht et leurs utilisations
FR2884516B1 (fr) Antagonistes npy, preparation et utilisations
DE60130633D1 (de) Gesicherte Internet-Zwischenablage
FR2911063B1 (fr) Structure de pont ruptible pour un stent, et stent incluant de telles structures de pont.
EP1723238A4 (fr) Virus oncolytiques modifies
NO20082454L (no) Anti-alfa2 integrin antistoffer og deres anvendelser
TW200609706A (en) Network interface controller circuitry
NO20044326D0 (no) Virale antigener
BRPI0611065A2 (pt) agente desespumente, e, composição de cimento.
NO20070826L (no) Seddelhandteringssystem
DE602005020457D1 (de) Master-slave-flip-flop, trigger-flip-flop und zähler
SE0400389L (sv) Resursdelande celler
GB0416487D0 (en) Modified virus
FR2903703B1 (fr) Genes codant pour la cis-labda-12,14-dien-8 alpha-ol (cis-abienol)synthase et la syn-copalyl-8-ol diphosphate synthase et leurs utilisations
FI20055013A0 (fi) Tiedonsiirtomenetelmä tiedonsiirtojärjestelmässä, kontrolleri ja tiedonsiirtopäätelaite
ES1061704Y (es) Pala plegadora.
MA28690B1 (fr) NUCLEOSIDES 3-ß-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIDIMINE ET LEURS UTILISATIONS
ES1057334Y (es) Edredon y colcha edredon.
ES1057781Y (es) Maquina expendedora de pan y/o bolleria.
ES1056684Y (es) Celula de carga discoidal.
ES1057560Y (es) Mesa-atril abatible y desmontable.
ES1056846Y (es) Panel de policarbonato y medios de anclaje.
GB0409596D0 (en) Novel herpes simplex viruses and uses thereof